PDCD1 and breast cancer: While these studies have suggested that a subgroup of patients with BC might benefit from immunotherapy targeting PD-1 and/or PD-L1, the expression of PD-1 on the T cells in the TME and that of PD-L1 on CSCs is not yet well-defined.